NR 565 FINAL EXAM 2 LATEST VERSIONS

• | P a g e

NR 565 FINAL EXAM 2 LATEST VERSIONS

ACTUAL EXAM NEWEST 2025 COMPLETE 200

QUESTIONS AND CORRECT DETAILED

ANSWERS (VERIFIED AN SWERS) |ALREADY

GRADED A+||BRAND NEW VERSION!!

What condition is indicated by acute symptoms of diabetes plus casual plasma glucose concentration greater than or equal to 200 mg/dL (casual defined as any time of day without regard to last

meal, classic symptoms: polyuria, polydipsia, unexplained

weight loss)?

• Pre-diabetes
• Diabetes mellitus

Correct answer: B. Diabetes mellitus

What condition is indicated by fasting plasma glucose greater than or equal to 126 mg/dL (fasting defined as no caloric intake for at least 8 hours)?

• Diabetes mellitus
• Pre-diabetes

Correct answer: A. Diabetes mellitus

What condition is indicated by 2-hour post-load plasma glucose in an oral glucose tolerance test greater than or equal to 200 mg/dL (test uses 75 g anhydrous glucose dissolved in water)?

• | P a g e

• Pre-diabetes
• Diabetes mellitus

Correct answer: B. Diabetes mellitus

What condition is indicated by HgbA1c greater than or equal to 6.5%?

• Diabetes mellitus
• Pre-diabetes

Correct answer: A. Diabetes mellitus

What condition is indicated by fasting plasma glucose 100 to 125 mg/dL (IFG)?

• Diabetes mellitus
• Pre-diabetes

Correct answer: B. Pre-diabetes

What condition is indicated by plasma glucose 140 to 199 mg/dL (IGT) 2 hours post-ingestion of standard glucose load (75 g)?

• Diabetes mellitus
• Pre-diabetes

Correct answer: B. Pre-diabetes

• | P a g e

What condition is indicated by HgbA1c 5.7% to 6.4%?

• Diabetes mellitus
• Pre-diabetes

Correct answer: B. Pre-diabetes

What does SGLT2i (Sodium-Glucose Cotransporter-2 Inhibitors) refer to, and what are examples?

• Sodium-Glucose Cotransporter-2 Inhibitors, names end in “-

ozin,” e.g., Canagliflozin (Invokana), Dapagliflozin (Farxiga), Empagliflozin (Jardiance)

• No specific class, no examples

Correct answer: A. Sodium-Glucose Cotransporter-2 Inhibitors,

names end in “-ozin,” e.g., Canagliflozin (Invokana), Dapagliflozin (Farxiga), Empagliflozin (Jardiance)

What does Biguanides refer to, and what is an example?

• Biguanides, e.g., Metformin (Glucophage)
• No specific class, no examples

Correct answer: A. Biguanides, e.g., Metformin (Glucophage)

What does DPP-4i (Dipeptidyl Peptidase-4 Inhibitors) refer to, and what are examples?

• | P a g e

• Dipeptidyl Peptidase-4 Inhibitors, names end in “-iptin,” e.g.,

Sitagliptin, Saxagliptin, Linagliptin, Alogliptin

• No specific class, no examples

Correct answer: A. Dipeptidyl Peptidase-4 Inhibitors, names end

in “-iptin,” e.g., Sitagliptin, Saxagliptin, Linagliptin, Alogliptin

What does Sulfonylureas refer to, and what are examples?

• Sulfonylureas, names often contain “gly” or “gli,” e.g.,

Glipizide, Glyburide, Glimepiride

• No specific class, no examples

Correct answer: A. Sulfonylureas, names often contain “gly” or

“gli,” e.g., Glipizide, Glyburide, Glimepiride

What does GLP-1 (Glucagon-like Peptide 1 Receptor Agonists) refer to, and what are examples?

• Glucagon-like Peptide 1 Receptor Agonists, names often end

in “-glutides,” e.g., Dulaglutide (Trulicity), Semaglutide (Ozempic), Liraglutide (Victoza)

• No specific class, no examples

Correct answer: A. Glucagon-like Peptide 1 Receptor Agonists,

names often end in “-glutides,” e.g., Dulaglutide (Trulicity), Semaglutide (Ozempic), Liraglutide (Victoza)